Cell and Organ Transplantology. 2014; 2(2):140-143.
DOI: 10.22494/COT.V2I2.31
Placental stem cells: biological characteristics and approaches to clinical application
Nasadyuk C. M.
Institute of Cell Therapy, Kyiv, Ukraine
Abstract
Literary data gives evidence that placenta is a rich source of stem cells that phenotypically correspond to human mesenchymal stem cells. The possibility of osteogenic and hepatogenic differentiation of placental mesenchymal stem cells was reported as well as their transformation into cardiomyocytes, adipocytes was shown. It was established that mesenchymal stem cells of placenta have the highest potential of osteogenic differentiation compared to the stem cells from other sources. The advantages of placental stem cells towards clinical application are ethical feasibility and non-invasive collection, high proliferative potential and immunomodulatory properties.
| 1. Nasadyuk CM. Cell Technology in Reproduction, Obstetrics and Gynecology. Cell and organ transplantology, 2013; 1(1):61-65. https://doi.org/10.22494/cot.v1i1.46 |
||||
| 2. Nasadyuk CM. Bіohіmіchna harakteristika ta pіdhodi do zastosuvannja ekstraktіv placenti v medichnіj prakticі [Biochemical characteristics and approaches to the use of placental extracts in medical practice]. З турботою про жінку – Caring for woman, 2013; 4(43): 54-56. | ||||
| 3. Nasadyuk CM. Pupovinna krov: mediko-bіologіchna harakteristika, zberіgannja, klіnіchne zastosuvannja Пуповинна кров: медико-біологічна характеристика, зберігання, клінічне застосування [Umbilical cord blood: medical and biological characterization, storage and clinical application]. Zhіnochij lіkar – Female doctor, 2009; 5: 53-56. | ||||
| 5. Overview of the Word Congress on Cord Blood and Innovative Approaches to The Treatment of Sickle-Cell Anemia in Monaco on 24-27 th October 2013. Cell and organ transplantology, 2014; 2(1):95-98. | ||||
| 6. Abumaree M H, Jumah A l. The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS). Int J Mol Sci. 2012; 13(7): 9298 – 9331. PMid:22942767 PMCid:PMC3430298 |
||||
| 7. Barcena A, Muench MO, Kapidzic M. Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion. 2011; 51(4): 94S-105S. https://doi.org/10.1111/j.1537-2995.2011.03372.x PMid:22074633 PMCid:PMC3266842 |
||||
| 8. Chakraborty PD, De D, Bandyopadhyay S, et al. Human aqueous placental extract as a wound healer. J. Wound Care. 2009; 18:462-467. https://doi.org/10.12968/jowc.2009.18.11.44987 PMid:19901875 |
||||
| 9. Chen J, Shehadah A, Pal A, et al. Neuroprotective effect of human placenta-derived cell treatment of stroke in rats. Cell Transplant. 2013; 22(5): 871. https://doi.org/10.3727/096368911X637380 PMid:22469567 |
||||
| 10. Fan Z X, Lu Y, Deng L, et al. Placenta- versus bone-marrow-derived mesenchymal cells for the repair of segmental bone defects in a rabbit model. FEBS J. 2012; 279(13): 2455-2465. https://doi.org/10.1111/j.1742-4658.2012.08625.x PMid:22564891 |
||||
| 11. Fazekasova H, Lechler R, Langford K, et al. Placenta derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs J. Tissue Eng and Regen Med. 2011; 5(9): 684-694. https://doi.org/10.1002/term.362 PMid:21953866 |
||||
| 12. Fisher-Shoval Y, Barhum Y, Sadan O, et al. Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS. J. Mol. Neurosci. 2012; 48(1): 176-184. https://doi.org/10.1007/s12031-012-9805-6 PMid:22638856 |
||||
| 13. Ilic N, Brooke G, Murray P, et al. Manufacture of clinical grade human placenta-derived multipotent mesenchymal stromal cells. Methods Mol. Biol. 2011; 698: 89-106. https://doi.org/10.1007/978-1-60761-999-4_8 PMid:21431513 |
||||
| 14. Lee JM, Jung J, Lee HJ, et al. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int. Immunopharmacol. 2012; 13(2): 219-224. https://doi.org/10.1016/j.intimp.2012.03.024 PMid:22487126 |
||||
| 15. Lee HJ, Jung J, Cho KJ, et al. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes. Differentiation. 2012; 84(3): 223-231. https://doi.org/10.1016/j.diff.2012.05.007 PMid:22885322 |
||||
| 16. Li F, Chen YZ, Miao ZN, et al. Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects. Cell Reprogram. 2012; 14(4): 334-341. PMid:22816556 |
||||
| 17. Li K, Li SZ, Zhang YL, et al. The effects of dan-shen root on cardiomyogenic differentiation of human placenta-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2011; 415(1):147-151. https://doi.org/10.1016/j.bbrc.2011.10.035 PMid:22020077 |
||||
| 18. Li J, Zhang H, Liu G. Research on anti-aging effect of mouse placenta cells transplantation. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010; 27(6):1312-6. PMid:21374985 |
||||
| 19. Lu GH, Yong WS, Xu ZM, et al. H. Human placental decidua basalis-derived mesenchymal stem cells differentiate into dopamine neuron-like cells with no response to long-term culture in vitro. Neuroreport. 2012; 30(23): 513-518. https://doi.org/10.1097/WNR.0b013e328353fbb4 PMid:22525837 |
||||
| 20. Malek A, Bersinger NA. Human placental stem cells: biomedical potential and clinical relevance. J. Stem Cells. 2011; 6(2): 75-92. PMid:22997848 |
||||
| 21. Oh EJ, Kim TK, Shin JH, et al. Biologic filler using human fibroblasts and placenta extracts. J. Craniofac. Surg. 2011; 22(5): 1557-1560. https://doi.org/10.1097/SCS.0b013e31822e5c5e PMid:21959386 |
||||
| 22. Park S, Kim E, Koh SE. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson’s disease model rats and alleviation of asymmetric rotational behavior. Brain Res. 2012; 1466: 158-166. https://doi.org/10.1016/j.brainres.2012.05.032 PMid:22634376 |
||||
| 23. Prather WR, Toren A, Meiron M, et al. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy. 2009; 11(4): 427-34. https://doi.org/10.1080/14653240902849762 PMid:19526389 |
||||
| 24. Sun NZ, Ji H. In vitro differentiation of osteocytes and adipocytes from human placenta-derived cells. J. Int. Med. Res. 2012; 40(2): 761-767. https://doi.org/10.1177/147323001204000242 PMid:22613441 |
||||
| 25. Takeda Y, Uemura S, Iwama H, et al. Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arterogenesis andimproves survival after myocardial infarction. Circ. J. 2009; 73(9): 1674-1682. https://doi.org/10.1253/circj.CJ-08-1067 PMid:19602778 |
||||
| 26. Young PP, Schäfer R. Cell-based therapies for cardiac disease: a cellular therapist’s perspective Transfusion. 2014. http://www.ncbi.nlm.nih.gov/pubmed/?term=Cell-based+therapies+for+cardiac+disease%3A+a+cellular+therapist%27s+perspective. | ||||
| 27. Zhang D, Tong A, Zhou L, et al. Osteogenic differentiation of human placenta-derived mesenchymal stem cells (PMSCs) on electrospun nanofiber meshes. Cytotechnology. 2012; 64(6): 701-710. https://doi.org/10.1007/s10616-012-9450-5 PMid:22526490 PMCid:PMC3488365 |
||||
| 28. Zhong ZN, Zhu SF, Yuan AD, et al. Potential of placenta-derive mesenchymal stem cells for bone tissue engineering: preliminary study of osteoblastic differentiation and immunogenicity. Orthopedics. 2012; 35(9):779-788. https://doi.org/10.3928/01477447-20120822-07 PMid:22955387 |
||||
| 29. http://clinicaltrials.gov/ | ||||
Nasadyuk CM. Рlacental stem cells: biological characteristics and approaches to clinical application. Cell and Organ Transplantology. 2014; 2(2):140-143. doi: 10.22494/COT.V2I2.31
